Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,016.00    0.00 (0.00%)
Bid:
1,022.00
Ask:
1,026.00
Spread: 4.00 (0.391%)
Market Cap: £145.79b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Dividend declaration & agreement to call 2025 AGM

26 Feb 2025 07:00

RNS Number : 4432Y
Banco Santander S.A.
25 February 2025
 

Banco Santander, S.A. ("Banco Santander" or the "Bank"), in compliance with the Securities Market legislation, hereby communicates the following:

INSIDE INFORMATION

 

The board of directors of Banco Santander, S.A. has resolved to submit to the 2025 Annual Shareholders' Meeting, in application of the Bank's current shareholder remuneration policy, the approval of the payment against 2024 results of a final gross cash dividend of €11 cents per share entitled to receive dividends. Subject to the approval of the 2025 Annual Shareholders' Meeting, the dividend would be payable from 2 May 2025. Thus, the last day to trade shares with a right to receive the dividend would be 28 April, the ex-dividend date would be 29 April and the record date would be 30 April.

The 2025 Annual Shareholders' Meeting will be called in the coming days to be held on 3 April 2025, on first call, or on 4 April 2025, on second call, with the agenda below. The meeting is expected to be held on second call.

 

Agenda for the 2025 AGM

1 Annual accounts and corporate management.

1 A Annual accounts and directors' reports of Banco Santander, S.A. and of its consolidated group for 2024.

1 B Consolidated statement of non-financial information for 2024, which is part of the consolidated directors' report.

1 C Corporate management for 2024.

2 Application of results obtained during 2024.

3 Board of Directors: appointment and re-election of directors.

3 A Setting of the number of directors.

3 B Re-election of Mr Luis Isasi Fernández de Bobadilla.

3 C Re-election of Mr Héctor Blas Grisi Checa.

3 D Re-election of Mr Glenn Hogan Hutchins.

3 E Re-election of Mrs Pamela Ann Walkden.

3 F Re-election of Ms Ana Botín-Sanz de Sautuola y O'Shea.

4 Re-election of the external auditor for financial year 2025.

5 Appointment of the verifier of sustainability information for financial year 2025.

6 Share capital.

6 A Reduction in share capital in the maximum amount of EUR 706,871,648, through the cancellation of a maximum of 1,413,743,296 own shares. Delegation of powers.

6 B Reduction in share capital in the maximum amount of EUR 757,624,616, through the cancellation of a maximum of 1,515,249,232 own shares. Delegation of powers.

7 Remuneration.

7 A Directors' remuneration policy.

7 B Setting of the maximum amount of annual remuneration to be paid to all the directors in their capacity as such.

7 C Approval of maximum ratio between fixed and variable components of total remuneration of executive directors and other employees belonging to categories with professional activities that have a material impact on the risk profile.

7 D Deferred Multiyear Objectives Variable Remuneration Plan.

7 E Application of the Group's buyout regulations.

7 F Annual directors' remuneration report (consultative vote).

8 Authorisation to the board and grant of powers for conversion into public instrument.

 

 

Boadilla del Monte (Madrid), 25 February 2025

 

IMPORTANT INFORMATION

Does Not Constitute an Offer of Securities

Neither this document nor the information contained herein constitutes an offer to sell or a solicitation of an offer to purchase securities.

Past Performance Is Not Indicative of Future Results

Statements regarding historical performance or growth rates are not intended to imply that future performance, stock price, or future results (including earnings per share) for a given period will necessarily match or exceed those of a previous period. Nothing in this document should be construed as a profit forecast.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAPASADSSEFA
Date   Source Headline
25th Jun 202611:35 amRNSBuyback programme: transactions 18-24June
18th Jun 202611:05 amRNSBuyback programme: transactions 11-17June
11th Jun 202611:02 amRNSBuyback programme: transactions 4-10June
10th Jun 20268:35 amRNSResult of Tender Offer
5th Jun 20263:06 pmRNSDirector/PDMR Shareholding
4th Jun 202611:05 amRNSBuyback programme: transactions 28May-3June
1st Jun 20264:47 pmRNSTotal Voting Rights
28th May 20267:00 amRNSAT1s Contingent Convertible securities
27th May 20268:26 amRNSOffer to purchase outstanding instruments
27th May 20268:21 amRNSResumption of the share buyback programme
13th May 20263:03 pmRNSRating granted by Fitch Ratings
6th May 20263:08 pmRNSDirector/PDMR Shareholding
1st May 20267:08 amRNSFurther re: Santander to acquire TSB
30th Apr 20264:59 pmRNSTotal Voting Rights
29th Apr 20267:00 amRNS1Q2026 Financial report & Earnings presentation
29th Apr 20267:00 amRNSFirst Quarter 2026 Results - Press release
24th Apr 202611:14 amRNSBuyback programme: transactions 16-23Apr
23rd Apr 20267:40 amRNSProspectus Exemption
23rd Apr 20267:25 amRNSTemporary suspension of the share buyback program
22nd Apr 202611:09 amRNS1st Quarter 2026 Results Notice
16th Apr 202611:04 amRNSBuyback programme: transactions 8-15Apr
14th Apr 20264:58 pmRNSSantander informs of the MREL determined by SRB
8th Apr 202611:07 amRNSBuyback programme: transactions 26Mar-7Apr
31st Mar 20264:44 pmRNSTotal Voting Rights
27th Mar 20262:26 pmRNS2026 AGM - Resolutions
27th Mar 20267:06 amRNSSantander expects higher profit&reaffirms targets
26th Mar 202610:12 amRNSBuyback programme: transactions 19-25Mar
19th Mar 20265:01 pmRNSDirector/PDMR Shareholding
19th Mar 202611:17 amRNSBuyback programme: transactions 12-18Mar
13th Mar 20264:37 pmRNSDirector/PDMR Shareholding
12th Mar 202611:10 amRNSBuyback programme: transactions 5-11Mar
9th Mar 202611:17 amRNSDirector/PDMR Shareholding
9th Mar 202611:14 amRNSDirector/PDMR Shareholding
6th Mar 20264:18 pmRNSDirector/PDMR Shareholding
5th Mar 202611:16 amRNSBuyback programme: transactions 27Feb-4Mar
4th Mar 20265:58 pmRNSDirector/PDMR Shareholding
2nd Mar 20265:57 pmRNSTotal Voting Rights
27th Feb 202611:18 amRNSBuyback programme: transactions 19-26Feb
25th Feb 20266:01 pmRNSNotice of AGM
25th Feb 20265:20 pmRNS2025 UK Annual Report
25th Feb 20262:19 pmRNSInvestor Day: Group CFO presentation
25th Feb 202612:42 pmRNSInvestor Day: Group CEO presentation
25th Feb 202612:37 pmRNSInvestor Day: Executive chair presentation
25th Feb 20267:03 amRNSStrategic plans, profit forecasts & payout policy
25th Feb 20267:00 amRNSDividend declaration & agreement to call 2026 AGM
24th Feb 20263:05 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:54 pmRNSDirector/PDMR Shareholding
19th Feb 202611:29 amRNSBuyback programme: transactions 12-18Feb
18th Feb 20264:48 pmRNSDirector/PDMR Shareholding
18th Feb 202611:07 amRNSInvestor Day meeting announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.